Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
Clinical trial NCT00752973 · COMPLETED
Trial details
- NCT number
- NCT00752973
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.